Insights from Probiota 2023 Pharmabiotics: Young startups set for "hard time" in 2023 as investors look to de-risk 20-Feb-2023 By Olivia Haslam While the future of microbiome drug advancements looks bright, young startups may struggle to gain funding as investors aim to mitigate risk in the face of a wider unstable landscape.